Seven Fleet Capital Management LP
114 holdingsFiling period: 2026-03-31Current AUM: $350.8Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | CGON | CG ONCOLOGY INC | 1.44M | $97.4M | $102.5M | 29.21% | -- | 2026-03-31 |
| 2 | TNGX | TANGO THERAPEUTICS INC | 502.0K | $10.5M | $13.6M | 3.89% | +286.8K | 2026-03-31 |
| 3 | RVMD | REVOLUTION MEDICINES INC | 80.8K | $7.9M | $15.2M | 4.32% | +15.0K | 2026-03-31 |
| 4 | TYRA | TYRA BIOSCIENCES INC | 195.7K | $7.5M | $6.2M | 1.78% | +116.1K | 2026-03-31 |
| 5 | LQDA | LIQUIDIA CORPORATION | 187.9K | $7.1M | $15.8M | 4.50% | +96.6K | 2026-03-31 |
| 6 | AGIO | AGIOS PHARMACEUTICALS INC | 209.5K | $7.1M | $6.3M | 1.79% | +177.8K | 2026-03-31 |
| 7 | IPSC | CENTURY THERAPEUTICS INC | 2.95M | $6.7M | $6.0M | 1.70% | -- | 2026-03-31 |
| 8 | ELVN | ENLIVEN THERAPEUTICS INC | 164.0K | $6.4M | $9.0M | 2.56% | +152.3K | 2026-03-31 |
| 9 | PCVX | VAXCYTE INC | 108.5K | $6.3M | $5.9M | 1.67% | +83.1K | 2026-03-31 |
| 10 | TNGX | TANGO THERAPEUTICS INC | 300.6K | $6.3M | $8.2M | 2.33% | -- | 2026-03-31 |
| 11 | COGT | COGENT BIOSCIENCES INC | 149.4K | $5.8M | $5.8M | 1.66% | +95.4K | 2026-03-31 |
| 12 | AVTX | AVALO THERAPEUTICS INC | 360.1K | $5.4M | $6.6M | 1.87% | -- | 2026-03-31 |
| 13 | NERV | MINERVA NEUROSCIENCES INC | 889.3K | $5.4M | $3.5M | 1.01% | -- | 2026-03-31 |
| 14 | CGON | CG ONCOLOGY INC | 75.8K | $5.1M | $5.4M | 1.54% | -1,439,393 | 2026-03-31 |
| 15 | — | PHARVARIS N V | 172.7K | $4.9M | $4.9M | 1.39% | +117.4K | 2026-03-31 |
| 16 | ABVX | ABIVAX SA | 43.1K | $4.8M | $5.4M | 1.53% | +43.0K | 2026-03-31 |
| 17 | DNTH | DIANTHUS THERAPEUTICS INC | 54.3K | $4.6M | $5.8M | 1.65% | +39.6K | 2026-03-31 |
| 18 | — | PHARVARIS N V | 144.0K | $4.1M | $4.1M | 1.16% | -- | 2026-03-31 |
| 19 | CYTK | CYTOKINETICS INC | 61.3K | $4.0M | $4.7M | 1.35% | +50.9K | 2026-03-31 |
| 20 | SLNO | SOLENO THERAPEUTICS INC | 115.8K | $3.9M | $3.9M | 1.10% | -14,309 | 2026-03-31 |
| 21 | ELVN | ENLIVEN THERAPEUTICS INC | 95.3K | $3.7M | $5.2M | 1.49% | -- | 2026-03-31 |
| 22 | ERAS | ERASCA INC | 222.5K | $3.6M | $4.0M | 1.15% | -- | 2026-03-31 |
| 23 | — | ROIVANT SCIENCES LTD | 128.2K | $3.5M | $3.5M | 1.01% | -- | 2026-03-31 |
| 24 | CTMX | CYTOMX THERAPEUTICS INC. | 714.0K | $3.4M | $2.2M | 0.63% | -- | 2026-03-31 |
| 25 | AVTX | AVALO THERAPEUTICS INC | 213.8K | $3.2M | $3.9M | 1.11% | +150.5K | 2026-03-31 |
← Scroll →
Page 1 of 5